
Shionogi & Co Investor Relations Material
Latest events

Q4 2025
13 May, 2025

Q3 2025
31 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shionogi & Co Ltd
Access all reports
Shionogi & Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's core business areas include prescription drugs, over-the-counter medications, and diagnostic products. Shionogi focuses on therapeutic areas such as infectious diseases, pain management, and cardiovascular diseases. It also provides contract development and manufacturing services to other pharmaceutical companies. Shionogi & Co., Ltd. is headquartered in Osaka, Japan, and its shares are listed on the TYO.
Key slides for Shionogi & Co Ltd


Q3 2025
Shionogi & Co Ltd


Q2 2025
Shionogi & Co Ltd
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
4507
Country
🇯🇵 Japan